Gene Expression in Hyperparathyroidism
Terminated
- Conditions
- HyperparathyroidismParathyroid Disease
- Interventions
- Other: Chart ReviewOther: HRPT2 Mutation Evaluation
- First Posted Date
- 2017-02-07
- Last Posted Date
- 2019-05-23
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 22
- Registration Number
- NCT03044600
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)
Active, not recruiting
- Conditions
- Genetic MutationMEN1
- Interventions
- Other: Chart ReviewBehavioral: Questionnaire
- First Posted Date
- 2017-02-06
- Last Posted Date
- 2019-05-23
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 45
- Registration Number
- NCT03043508
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care Clinic
Completed
- Conditions
- Malignant Neoplasms of Independent (Primary) Multiple Sites
- Interventions
- Behavioral: Questionnaires
- First Posted Date
- 2017-02-06
- Last Posted Date
- 2023-03-28
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 201
- Registration Number
- NCT03043378
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Ruxolitinib Phosphate in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Phase 2
Completed
- Conditions
- Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUntreated Chronic Lymphocytic Leukemia
- Interventions
- First Posted Date
- 2017-02-03
- Last Posted Date
- 2021-04-21
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 1
- Registration Number
- NCT03041636
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Wearable Exercise Trackers in Cancer Rehabilitation
Not Applicable
Completed
- Conditions
- In Situ NeoplasmsMalignant Neoplasms of Independent (Primary) Multiple SitesBenign Neoplasms
- Interventions
- Behavioral: QuestionnairesDevice: Wearable Exercise Tracker Watch
- First Posted Date
- 2017-02-03
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 111
- Registration Number
- NCT03042884
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer
Phase 2
Completed
- Conditions
- VomitingMalignant NeoplasmNausea
- Interventions
- Other: PlaceboOther: Questionnaire Administration
- First Posted Date
- 2017-02-02
- Last Posted Date
- 2023-10-17
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 53
- Registration Number
- NCT03040726
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Molecular and Immunohistochemical Profiling of Tumors in Patients with Parathyroid Tumors
Recruiting
- Conditions
- Parathyroid Gland CarcinomaPrimary HyperparathyroidismParathyroid Gland AdenomaParathyroid Gland Atypical Adenoma
- Interventions
- Procedure: Biospecimen CollectionOther: Laboratory Biomarker Analysis
- First Posted Date
- 2017-02-01
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 310
- Registration Number
- NCT03039439
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Impact of a Systematic Social Work Driven Approach on Medical Power of Attorney Documentation, Knowledge, Attitudes, and Beliefs in Participants With Stage I-IV Gynecological Cancers
Not Applicable
Completed
- Conditions
- Malignant Female Reproductive System NeoplasmCaregiver
- Interventions
- Other: Questionnaire AdministrationOther: Video
- First Posted Date
- 2017-01-31
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 731
- Registration Number
- NCT03037346
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery
Phase 4
Completed
- Conditions
- Stage IIIA Breast Cancer AJCC v7Stage IIA Breast Cancer AJCC v6 and v7Stage IIIB Breast Cancer AJCC v7Breast Carcinoma Metastatic in Lymph NodeStage II Breast Cancer AJCC v6 and v7Stage IIB Breast Cancer AJCC v6 and v7
- Interventions
- Procedure: Axillary Lymph Node DissectionProcedure: LocalizationDevice: Medical Device
- First Posted Date
- 2017-01-31
- Last Posted Date
- 2021-03-05
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 54
- Registration Number
- NCT03038152
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors
Phase 2
Active, not recruiting
- Conditions
- Weight LossMetastatic Malignant Solid NeoplasmCancer FatigueC-Reactive Protein MeasurementRecurrent Malignant Solid NeoplasmAdvanced Malignant Solid Neoplasm
- Interventions
- Behavioral: Exercise InterventionOther: Laboratory Biomarker AnalysisOther: Nutritional AssessmentOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2017-01-30
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 129
- Registration Number
- NCT03035409
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath